Back to Search Start Over

Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis.

Authors :
Nawrocki S
Cha J
Source :
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Apr; Vol. 82 (4), pp. 969-979. Date of Electronic Publication: 2019 Dec 04.
Publication Year :
2020

Abstract

Hyperhidrosis is a dermatological condition defined by excessive sweating beyond thermoregulatory needs with significant effects on patients' quality of life. Hyperhidrosis is categorized as primary or secondary: primary hyperhidrosis is mostly focal and idiopathic, whereas secondary hyperhidrosis is commonly generalized and caused by an underlying medical condition or use of medications. Various surgical and nonsurgical therapies exist for primary hyperhidrosis. Although botulinum toxin is one of the deadliest toxins known, when used in small doses, it is one of the most effective therapies for primary hyperhidrosis. Botulinum toxin injections are widely used as a second-line primary hyperhidrosis treatment option once topical treatment strategies have failed. This article provides an overview of the commercially available botulinum toxin formulations and their applications in the treatment of primary hyperhidrosis.<br /> (Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1097-6787
Volume :
82
Issue :
4
Database :
MEDLINE
Journal :
Journal of the American Academy of Dermatology
Publication Type :
Academic Journal
Accession number :
31811879
Full Text :
https://doi.org/10.1016/j.jaad.2019.11.042